Search results for "breast neoplasms"

showing 10 items of 804 documents

Male breast cancer.

2010

Male breast cancer (MaleBC) is a rare disease, accounting for <1% of all male tumors. During the last few years, there has been an increase in the incidence of this disease, along with the increase in female breast cancer (FBC). Little is known about the etiology of MaleBC: hormonal, environmental and genetic factors have been reported to be involved in its pathogenesis. Major risk factors include clinical disorders carrying hormonal imbalances, radiation exposure and, in particular, a positive family history (FH) for BC, the latter suggestive of genetic susceptibility. Rare mutations in high-penetrance genes (BRCA1 and BRCA2) confer a high risk of BC development; low-penetrance gene mutati…

CounselingMalemedicine.medical_specialtymedicine.medical_treatmentchemotherapyHyperestrogenismsurvivalBreast Neoplasms MalesurgeryBreast cancerRisk Factorspolycyclic compoundsmedicineHumansgeneticsFamily historyskin and connective tissue diseaseshormonal treatmentneoplasmsradiotherapyGynecologytherapybusiness.industryCarcinomaCancerHematologybacterial infections and mycosesmedicine.diseasePrognosisMale breast cancergenetics; hormonal treatment; male breast cancer; survival; local recurrence; radiotherapy; therapy; surgery; chemotherapyRadiation therapyOncologyMale breast cancerbacteriaFemaleBreast diseaselocal recurrencemedicine.symptombusinessAlgorithmsRare disease
researchProduct

Fertility and breast cancer: A literature review of counseling, preservation options and outcomes.

2021

Fertility preservation is an important issue in breast cancer patients undergoing oncological treatment. Fertility counseling is a crucial need given the physical and psychological stress experienced by patients. Cryopreservation of mature oocytes is currently the standard fertility-preserving procedure. Other options such as ovarian tissue preservation or gonadal protection during chemotherapy are still experimental, but have proven effectiveness. Prompt referral to a fertility unit is highly recommended in order to ensure quality of care. In this article, we focus on the different strategies to preserve fertility in breast cancer patients, assessing also the safety of pregnancy and breast…

Counselingmedicine.medical_specialtyReferralmedia_common.quotation_subjectBreastfeedingFertilityBreast NeoplasmsBreast cancerPregnancymedicineHumansFertility preservationmedia_commonClinical OncologyCryopreservationPregnancybusiness.industryCancerFertility PreservationHematologymedicine.diseaseFertilityOncologyFamily medicineOocytesFemalebusinessCritical reviews in oncology/hematology
researchProduct

Myc Promoter-Binding Protein-1 (MBP-1) Is a Novel Potential Prognostic Marker in Invasive Ductal Breast Carcinoma

2010

BackgroundAlpha-enolase is a glycolytic enzyme that catalyses the formation of phosphoenolpyruvate in the cell cytoplasm. α-Enolase and the predominantly nuclear Myc promoter-binding protein-1 (MBP-1) originate from a single gene through the alternative use of translational starting sites. MBP-1 binds to the P2 c-myc promoter and competes with TATA-box binding protein (TBP) to suppress gene transcription. Although several studies have shown an antiproliferative effect of MBP-1 overexpression on several human cancer cells, to date detailed observations of α-enolase and MBP-1 relative expression in primary tumors versus normal tissues and their correlation with clinicopathological features ha…

CytoplasmAlpha-enolasePROGRESSIONAged 80 and overRegulation of gene expressionMultidisciplinaryQRGenetics and Genomics/Gene ExpressionMiddle AgedPrognosisPathology/Molecular PathologyNUDE-MICETransport proteinCarcinoma DuctalDNA-Binding ProteinsGene Expression Regulation NeoplasticProtein Transportmedicine.anatomical_structureGLYCOLYTIC ENZYMEOncology/Breast CancerMedicineCELL LUNG-CANCER; ALPHA-ENOLASE; PROTEOMIC ANALYSIS; GLYCOLYTIC ENZYME; NUDE-MICE; GENE; IDENTIFICATION; PROGRESSION; EXPRESSION; METASTASESFemalePROTEOMIC ANALYSISEnolase MBP-1 Breast cancer ImmunohistochemistryResearch ArticleAdultEXPRESSIONScienceCELL LUNG-CANCERBreast NeoplasmsBiologyDNA-binding proteinBiomarkers TumormedicineHumansNeoplasm InvasivenessGeneAgedCell NucleusIDENTIFICATIONBinding proteinALPHA-ENOLASEGENEMolecular biologySettore BIO/18 - GeneticaCell nucleusMETASTASESCytoplasmPhosphopyruvate Hydratasebiology.proteinPLoS ONE
researchProduct

The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer

2007

Antibody-based cancer immunotherapy relies on the identification and characterization of target antigens and the development of potent antibodies recognizing the target. Here we report the expression analysis and molecular characterization of the differentiation antigen NY-BR-1, which we previously identified by using the SEREX (serological analysis of recombinant cDNA expression libraries) method. Corroborating methodologies, including mRNA quantitation and immunoblotting show that NY-BR-1 is strongly expressed in >70% of 129 breast tumors. Application of a NY-BR-1 specific antibody demonstrated NY-BR-1 expression in primary and metastastic breast cancers. In contrast, most of the breast c…

CytoplasmCancer ResearchPathologymedicine.medical_specialtyRecombinant Fusion Proteinsmedicine.medical_treatmentCellular differentiationGreen Fluorescent ProteinsImmunoblottingBreast NeoplasmsBiologyTargeted therapyBreast cancerAntigenCancer immunotherapyAntigens NeoplasmCell Line TumormedicineHumansRNA MessengerBinding SitesMicroscopy ConfocalReverse Transcriptase Polymerase Chain ReactionCell MembraneAntibodies MonoclonalMembrane ProteinsFlow Cytometrymedicine.diseaseAntigens DifferentiationImmunohistochemistryTumor antigenGene Expression Regulation NeoplasticOncologyCancer researchbiology.proteinImmunohistochemistryFemaleAntibodyHydrophobic and Hydrophilic InteractionsInternational Journal of Cancer
researchProduct

A loop involving NRF2, miR‐29b‐1‐5p and AKT, regulates cell fate of MDA‐MB‐231 triple‐negative breast cancer cells

2019

The present study shows that nuclear factor erythroid 2-related factor 2 (NRF2) and miR-29b-1-5p are two opposite forces which could regulate the fate of MDA-MB-231 cells, the most studied triple-negative breast cancer (TNBC) cell line. We show that NRF2 activation stimulates cell growth and markedly reduces reactive oxygen species (ROS) generation, whereas miR-29b-1-5p overexpression increases ROS generation and reduces cell proliferation. Moreover, NRF2 downregulates miR-29b-1-5p expression, whereas miR-29b-1-5p overexpression decreases p-AKT and p-NRF2. Furthermore, miR-29b-1-5p overexpression induces both inhibition of DNA N-methyltransferases (DNMT1, DNMT3A, and DNMT3B) expression and …

DNA (Cytosine-5-)-Methyltransferase 10301 basic medicineNF-E2-Related Factor 2PhysiologyClinical BiochemistryTriple Negative Breast NeoplasmsAKT DNMTs miR‐29b‐1‐5p NRF2 parthenolide tumor suppressor genesCell fate determinationenvironment and public healthDNA Methyltransferase 3A03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSettore BIO/10 - BiochimicaCell Line TumorCyclin D2HumansParthenolideDNA (Cytosine-5-)-MethyltransferasesProtein kinase BTriple-negative breast cancerCell Proliferationchemistry.chemical_classificationReactive oxygen speciesCell growthTumor Suppressor ProteinsCell BiologyDNA Methylationrespiratory systemCell biologyGene Expression Regulation NeoplasticMicroRNAs030104 developmental biologychemistryCell culture030220 oncology & carcinogenesisDNMT1FemaleReactive Oxygen SpeciesProto-Oncogene Proteins c-aktSesquiterpenesSignal TransductionJournal of Cellular Physiology
researchProduct

DNA polymeraseθ up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability

2010

“Replicative stress” is one of the main factors underlying neoplasia from its early stages. Genes involved in DNA synthesis may therefore represent an underexplored source of potential prognostic markers for cancer. To this aim, we generated gene expression profiles from two independent cohorts (France,n= 206; United Kingdom,n= 117) of patients with previously untreated primary breast cancers. We report here that among the 13 human nuclear DNA polymerase genes, DNA Polymerase θ (POLQ) is the only one significantly up-regulated in breast cancer compared with normal breast tissues. Importantly,POLQup-regulation significantly correlates with poor clinical outcome (4.3-fold increased risk of de…

DNA ReplicationGenome instabilityDNA damageDNA polymerase[SDV]Life Sciences [q-bio]DNA Polymerase ThetaBreast NeoplasmsDNA-Directed DNA PolymeraseKaplan-Meier Estimatemedicine.disease_causeBioinformaticsGenomic InstabilityCell LineCohort Studies03 medical and health sciences0302 clinical medicineBreast cancerCell Line TumorChromosome instabilityCyclin EmedicineHumansComputingMilieux_MISCELLANEOUS030304 developmental biology0303 health sciencesMultidisciplinarybiologyReverse Transcriptase Polymerase Chain ReactionGene Expression ProfilingCancerMiddle AgedBiological SciencesPrognosismedicine.diseaseUnited KingdomUp-RegulationGene Expression Regulation Neoplastic030220 oncology & carcinogenesisCancer researchbiology.proteinFemaleRNA InterferenceFranceCarcinogenesisDNA DamageProceedings of the National Academy of Sciences
researchProduct

Real-World Data Analysis of Pregnancy-Associated Breast Cancer at a Tertiary-Level Hospital in Romania

2020

Background and objectives: Breast cancer is among the most common cancer types encountered during pregnancy. Here, we aimed to describe the characteristics, management, and outcomes of women with pregnancy-associated breast cancer at a tertiary-level hospital in Romania. Material and Methods: We retrospectively and prospectively collected demographic, oncological, and obstetrical data for women diagnosed with cancer during pregnancy, and who elected to continue their pregnancy, between June 2012 and June 2020. Complete data were obtained regarding family and personal medical history and risks factors, cancer diagnosis and staging, clinical and pathological features (including histology and …

Data AnalysisPediatricsmedicine.medical_specialtymedicine.medical_treatmentbreast cancer; pregnancy-associated breast cancer; RomaniaBreast NeoplasmsArticleBreast cancerbreast cancerPregnancyAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansChildbirthMedical historyStage (cooking)ChildNeoplasm StagingRetrospective Studieslcsh:R5-920PregnancyChemotherapybusiness.industrypregnancy-associated breast cancerRomaniaCancerGeneral Medicinemedicine.diseaseHospitalsNeoadjuvant TherapyRadiation therapyFemaleNeoplasm Recurrence Locallcsh:Medicine (General)businessMedicina
researchProduct

A completely automated CAD system for mass detection in a large mammographic database.

2006

Mass localization plays a crucial role in computer-aided detection (CAD) systems for the classification of suspicious regions in mammograms. In this article we present a completely automated classification system for the detection of masses in digitized mammographic images. The tool system we discuss consists in three processing levels: (a) Image segmentation for the localization of regions of interest (ROIs). This step relies on an iterative dynamical threshold algorithm able to select iso-intensity closed contours around gray level maxima of the mammogram. (b) ROI characterization by means of textural features computed from the gray tone spatial dependence matrix (GTSDM), containing secon…

Databases FactualInformation Storage and RetrievalReproducibility of ResultsBreast NeoplasmsSensitivity and SpecificityNeural networkPattern Recognition AutomatedRadiographic Image EnhancementBreast cancerTextural featuresRadiology Information SystemsImage processingComputer-aided detection (CAD)Artificial IntelligenceCluster AnalysisDatabase Management SystemsHumansRadiographic Image Interpretation Computer-AssistedFemaleBreast cancer; Computer-aided detection (CAD); Image processing; Mammographic mass detection; Neural network; Textural featuresMammographic mass detectionAlgorithmsMammographyMedical physics
researchProduct

Fuzzy technique for microcalcifications clustering in digital mammograms

2012

Abstract Background Mammography has established itself as the most efficient technique for the identification of the pathological breast lesions. Among the various types of lesions, microcalcifications are the most difficult to identify since they are quite small (0.1-1.0 mm) and often poorly contrasted against an images background. Within this context, the Computer Aided Detection (CAD) systems could turn out to be very useful in breast cancer control. Methods In this paper we present a potentially powerful microcalcifications cluster enhancement method applicable to digital mammograms. The segmentation phase employs a form filter, obtained from LoG filter, to overcome the dependence from …

Databases FactualMicrocalcificationsBreast NeoplasmsContext (language use)CADcomputer.software_genreSensitivity and SpecificityFuzzy logicClusteringBreast cancerSegmentationBreast cancerC-meansImage Processing Computer-AssistedmedicineCluster AnalysisHumansMammographyRadiology Nuclear Medicine and imagingSegmentationCluster analysisSpatial filtersmedicine.diagnostic_testMultimediabusiness.industryCalcinosisPattern recognitionmedicine.diseaseSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Computer aided detectionFuzzy logicRadiology Nuclear Medicine and imagingFemaleArtificial intelligencebusinesscomputerAlgorithmsMammographyResearch ArticleBreast cancer Microcalcifications Spatial filters Clustering Fuzzy logic C-means Mammography SegmentationBMC Medical Imaging
researchProduct

Decorin transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC

2008

Decorin is a prototype member of the small leucine-rich proteoglycan family widely distributed in the extracellular matrices of many connective tissues, where it has been shown to play multiple important roles in the matrix assembly process, as well as in some cellular activities. A major interest for decorin function concerns its role in tumorigenesis, as growth-inhibitor of different neoplastic cells, and potential antimetastatic agent. The aim of our research was to investigate wide-ranged effects of transgenic decorin on breast cancer cells. To this purpose we utilized the well-characterized 8701-BC cell line, isolated from a ductal infiltrating carcinoma of the breast, and two derived …

DecorinTransgeneBlotting WesternOligonucleotidesBreast NeoplasmsBiologymedicine.disease_causeProteomicsBiochemistryproteomicsRheumatologyCell Line TumorSettore BIO/10 - BiochimicaCell AdhesionmedicineHumansElectrophoresis Gel Two-DimensionalOrthopedics and Sports MedicineSettore BIO/06 - Anatomia Comparata E CitologiaMolecular BiologyCell ProliferationdecorinExtracellular Matrix ProteinsCell growthGene Expression ProfilingCell BiologyTransfectionbrest cancer cellGene Expression Regulation Neoplasticcarbohydrates (lipids)Settore BIO/18 - GeneticaProteoglycanCell cultureMicroscopy Electron Scanningbiology.proteinCancer researchdecorin; brest cancer cells; proteomicsFemaleProteoglycansCarcinogenesis
researchProduct